China SXT Pharmaceuticals (SXTC) Retained Earnings (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Retained Earnings of -$34.2 million for Q1 2026, down 22.15% year-over-year from -$44.0 million in Q1 2025, and little changed quarter-over-quarter from -$34.4 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Retained Earnings (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Retained Earnings history runs 9 years deep, the most recent figure standing at -$34.2 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 22.15% year-over-year to -$34.2 million; the TTM figure through Mar 2026 stood at -$34.2 million (down 22.15% YoY), while the FY2026 annual figure was -$34.2 million, down 22.15% from the prior year.
- Retained Earnings for Q1 2026 stood at -$34.2 million, roughly flat from -$34.4 million in the prior quarter.
- The five-year high for Retained Earnings was $35.9 million in Q3 2023, with the low at -$34.4 million in Q3 2025.
- The 5-year median for Retained Earnings is -$21.6 million (2023), against an average of -$1.1 million.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings advanced 25.2% in 2022, then sank 202.98% in 2025.
- China SXT Pharmaceuticals' Retained Earnings stood at $32.6 million in 2022, then rose by 10.4% to $35.9 million in 2023, then declined by 7.12% to $33.4 million in 2024, then tumbled by 202.98% to -$34.4 million in 2025, then grew by 0.48% to -$34.2 million in 2026.
- Business Quant data shows SXTC's Retained Earnings at -$34.2 million in Q1 2026, -$34.4 million in Q3 2025, and -$28.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.11 Bn | 43.15 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.24 Bn | 39.59 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.84 Bn | 30.17 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.44 Bn | 19.78 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.03 Bn | 11.50 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.06 Bn | 9.89 Bn | - | 3.75 Bn |
| 10 | China SXT Pharmaceuticals | 34,663.68 | -28.14 Mn | - | -34.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.22 Mn |
| Sep 30, 2025 | -34.38 Mn |
| Mar 31, 2025 | -28.02 Mn |
| Sep 30, 2024 | 33.39 Mn |
| Mar 31, 2024 | -24.71 Mn |
| Sep 30, 2023 | 35.95 Mn |
| Mar 31, 2023 | -21.61 Mn |
| Sep 30, 2022 | 32.56 Mn |
| Mar 31, 2022 | 30.99 Mn |
| Sep 30, 2021 | 26.01 Mn |
| Mar 31, 2021 | 25.32 Mn |
| Sep 30, 2020 | 24.23 Mn |
| Mar 31, 2020 | 17.16 Mn |
| Sep 30, 2019 | 11.41 Mn |
| Mar 31, 2019 | 7.95 Mn |
| Sep 30, 2018 | 1.46 Mn |
| Mar 31, 2018 | 1.54 Mn |